Advertisement

Topics

Drug Pipeline for Macular Degeneration in Focus at AAO

07:19 EDT 19 Oct 2018 | Medscape

Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the American Academy of Ophthalmology meeting.
Medscape Medical News

Original Article: Drug Pipeline for Macular Degeneration in Focus at AAO

NEXT ARTICLE

More From BioPortfolio on "Drug Pipeline for Macular Degeneration in Focus at AAO"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...